News
Smartphone-powered trial backs J&J's Invokana for heart fail...
Johnson & Johnson's SGLT2 inhibitor Invokana has been shown to have a significant effect on heart failure symptoms in a clinical trial that relied entirely on remote monitoring of sympt
